InvestorsHub Logo

trding

11/01/22 9:15 AM

#215251 RE: misiu143 #215249

I understand why some don’t believe my story , most probably if I will not witness this myself



Yes, knowing you over the years I believed you 100% on the story. I believe there was several of these stories, one reason the price spike in March 2020. Its sad they couldn't get the trial setup correctly to show that. I believe someone said anecdotal people don't get up off the table on a vent (especially shortly after receiving leronlimab). That would be an extremely high coincidence to occur not once, but multiple times, which makes be believe it is closely connected.

that_little_voice

11/01/22 9:16 AM

#215252 RE: misiu143 #215249

You last post about this was your son was on deaths door and after 2 hours he was back to 100% and you wanted to give up his bed to another person as you felt guilty.

Now you are saying you weren't with your dying son? Also, you just said you didn't witness this as you were not next time him. With O2 sat 72% he was most likely not conscious so how do you know what doctors game him?

Cbrnlol

11/01/22 11:36 PM

#215268 RE: misiu143 #215249

As an actual healthcare provider, Leronliman is nowhere near as effective as other options it seems….. (I’m positive you weren’t one of the small groups who it was tested on as it’s an inventional drug lol). Not useful for Covid, or cancer.

They pumped a subpar / ineffective drug to sell shares. “With the conclusion of both the CD10 and CD12 clinical trials, it has become clear that the data currently available do not support the clinical benefit of leronlimab for the treatment of COVID-19. In the smaller study that CytoDyn conducted in patients with mild-to-moderate COVID-19 disease (CD10), there was no observed effect of the drug on the study’s primary endpoint or on any of the secondary endpoints.”